Tests a phone app for blood sugar logging in pregnant women with diabetes
Tests a phone app for blood sugar logs in pregnant women with diabetes.
Key facts
- Who runs it
- Carolyn Zahler-Miller
- Where
- Augusta, United StatesSee the site
- Trial code
- Registry title
- Mobile App Logging for Diabetes in Pregnancy
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 1 Jun 2024
- Expected to end
- 1 Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- OneTouch Reveal application
- Record updated
- 31 January 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women with type 2 diabetes or gestational diabetes. It compares a mobile app with paper logs for recording blood sugar.
- Age
- 18 years and older (up to 100 years).
- Sex
- Women only.
- Disease stage
- Type 2 diabetes or gestational diabetes; at least 12 weeks of pregnancy.
- Earlier treatment
- Must not already use a continuous glucose monitor or another mobile app to track glucose.
Main reasons for not taking part
- Less than 4 weeks expected to be left in the pregnancy
- Already uses a continuous glucose monitor or another glucose-tracking app
- Type 1 diabetes
- Does not speak English
This trial only enrols pregnant participants. The registry sentence this rests on: Verified intrauterine pregnancy
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- 18 years and older
- Verified intrauterine pregnancy
- At least 12 weeks gestation
- Diagnosed with either type 2 diabetes mellitus or gestational diabetes mellitus
Who cannot take part
- Type 1 diabetes mellitus
- Pre-existing use of a continuous glucose monitor or other mobile application for glucose tracking
- Patients with less than 4 weeks anticipated to be remaining in pregnancy
- Non-English speaking patients
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Where in United States
- Augusta UniversityAugusta, United StatesContact: Carolyn M Zahler-MillerTaking people
About the trial
What the trial wants to find out
To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
The 2 groups in the trial
- Mobile App armTreatment being tested
Patient will input their daily blood glucose levels (fasting and 2 hours after breakfast, lunch and dinner) into the OneTouch Reveal app
Treatment: OneTouch Reveal application
- Paper Log ArmNo study treatment, for comparison
Patients will input their daily blood glucose levels onto paper logs which is the current process in the prenatal clinic.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effect of a Mobile Application on Blood Sugar Testing Compliance in Pregnant Women With Diabetes
- Plain-language title
- Tests a phone app for blood sugar logging in pregnant women with diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06005987, who can take part
- Record updated
- 31 January 2025